Financials

  • Market Capitalization 779.14 M
  • Employee 61
  • Founded 2006
  • CEO N/A
  • Website www.zevra.com
  • Headquarter Delaware, United States
  • FIGI BBG0026ZG1F5
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
4.64
Relación precio/flujo de caja
4.39

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2592
IVA
Inventiva S.A. - American Depository Shares
4.30 USD0.00%+11.11%+11.69%+28.74%830.92 M USD
2609
CTMX
CytomX Therapeutics, Inc. - Common Stock
3.70 USD-1.60%-3.90%+21.31%+56.12%805.50 M USD
2640
SPRY
ARS Pharmaceuticals, Inc. - Common Stock
7.74 USD-2.52%-8.40%-21.42%-15.96%768.61 M USD
2642
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
41.30 USD-2.94%+1.57%+24.25%+37.07%764.14 M USD

Noticias